Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02919592 · ClinicalTrials.gov registry record · NA
Memory Gel and Shape Combined Cohort
A NA study of Primary Breast Augmentation and Primary Breast Reconstruction, sponsored by Mentor Worldwide.
- Active
- Registry status
- NA
- Development phase
- 3,603
- Enrollment target
- 20
- Study locations
NCT02919592: Active NA study of Primary Breast Augmentation and Primary Breast Reconstruction, sponsored by Mentor Worldwide.
NCT02919592 is a NA study of Primary Breast Augmentation and Primary Breast Reconstruction that is active but no longer recruiting, run by Mentor Worldwide. The registered enrollment target is 3,603 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (157% higher). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02919592, a NA study of Primary Breast Augmentation and Primary Breast Reconstruction, is active but no longer recruiting, sponsored by Mentor Worldwide.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,603 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to collect additional post-approval clinical data on the long-term performance of MemoryShape and MemoryGel Breast Implants, as indicated for primary or revisional breast augmentation and primary or revisional breast reconstruction.
Conditions Studied
Interventions
- DEVICE MemoryShape® Breast Implants
- DEVICE MemoryGel® Breast Implants
- PROCEDURE Other Aesthetic Surgery
Study Locations (20)
California
- Jaime Schwartz, MD - Beverly Hills
- Susan E. Downey, MD Inc - Burbank
- Mohebali Plastic Surgery - Corte Madera
- Institute of Cosmetic and Reconstructive Surgery - Fountain Valley
- Newport Beach Center for Plastic Surgery - Newport Beach
- Newport Center for Special Surgery - Newport Beach
- North Coast Plastic Surgery - Oceanside
- Li Plastic Surgery - Ontario
- Summit Plastic Surgery - Redding
- Verve Plastic Surgery - Solana Beach
- Kaweah Delta Health Care District - Visalia
Arizona
- Advanced Plastic Surgery Institute - Gilbert
- Advanced Surgical Associates - Mesa
- Robles Plastic Surgery - Phoenix
- Berardi Aesthetics and Plastic Surgery - Scottsdale
- Guerra Plastic Surgery Center - Scottsdale
- Mark Malek, MD Plastic Surgery - Scottsdale
Alabama
- Hedden Plastic Surgery Center - Birmingham
- Plastic Surgery of Tuscaloosa - Tuscaloosa
Arkansas
- Vanderpool Cosmetic Plastic Surgery - Fayetteville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,603 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2031-09-16 |
| Phase | NA |
What the registry record for NCT02919592 still lists
NCT02919592 is an interventional study that assigns participants to a tested intervention. Its 3,603 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (157% higher).
The record links to 4 conditions, with Primary Breast Augmentation appearing as the primary indexed condition, and to 3 interventions - of which MemoryShape® Breast Implants is the first listed.
NCT02919592 names 20 study sites across 4 states, led by California, Arizona, Alabama.
Frequently Asked Questions
What is clinical trial NCT02919592 about?
NCT02919592 is a clinical study titled "Memory Gel and Shape Combined Cohort". The purpose of this study is to collect additional post-approval clinical data on the long-term performance of MemoryShape and MemoryGel Breast Implants, as indicated for primary or revisional breast augmentation and primary or revisional breast reconstruction.
What is the current status of trial NCT02919592?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,603 participants. The study started on 2016-09-01. Estimated completion is 2031-09-16.
What conditions does trial NCT02919592 study?
This clinical trial studies the following conditions: Primary Breast Augmentation, Primary Breast Reconstruction, Revision Breast Augmentation, Revision Breast Reconstruction.
What interventions are being tested in trial NCT02919592?
The interventions under investigation include: MemoryShape® Breast Implants (DEVICE), MemoryGel® Breast Implants (DEVICE), Other Aesthetic Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02919592?
This trial is sponsored by Mentor Worldwide, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02919592 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02919592's enrollment target sits among peer trials
3,603 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06088498 · 3,600 participants · Phase 2
App for Reducing Cravings to Smoke
- NCT06501118 · 3,600 participants · NA
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
- NCT06919419 · 3,600 participants · NA
HOTSPOT Study: Implement and Evaluate the PrEP (Pre-exposure Prophylaxis) Implementation Strategy
- NCT07091032 · 3,600 participants · NA
Building Connections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI